Question:hard
Which drug regimen is given in a pregnant woman with HIV infection?
Which drug regimen is given in a pregnant woman with HIV infection?
Show Hint
All three are valid two-NRTI backbones in pregnancy.
Updated On: Jun 24, 2026
- Tenofovir disoproxil fumarate with emtricitabine
- Tenofovir disoproxil fumarate with lamivudine
- Abacavir with lamivudine
- All
Show Solution
The Correct Option is D
Solution and Explanation
Step 1: Frame the regimen. Every pregnant patient on ART receives a backbone of two nucleoside reverse transcriptase inhibitors plus a third anchor drug. The question only asks about the NRTI backbone choices.
Step 2: Validate each pair. Tenofovir disoproxil fumarate with emtricitabine, tenofovir disoproxil fumarate with lamivudine, and abacavir with lamivudine are all recognized preferred two-NRTI combinations that traverse the placenta. Abacavir is used only when HLA-B5701 testing is negative.
Step 3: Conclude. Because all three options are individually correct backbones, the inclusive choice captures them together.
No single backbone is exclusively right, so the combined option wins.\[\boxed{\text{All}}\]
Step 2: Validate each pair. Tenofovir disoproxil fumarate with emtricitabine, tenofovir disoproxil fumarate with lamivudine, and abacavir with lamivudine are all recognized preferred two-NRTI combinations that traverse the placenta. Abacavir is used only when HLA-B5701 testing is negative.
Step 3: Conclude. Because all three options are individually correct backbones, the inclusive choice captures them together.
No single backbone is exclusively right, so the combined option wins.\[\boxed{\text{All}}\]
Was this answer helpful?
0
